Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten

7680677730016 CH-67773 Filmtabletten
Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten
Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten
Trikafta 100 mg / 50 mg / 75 mg, 150 mg, Filmtabletten
1 / 3
google

Article details

Package size
84 (4 x 21)
Selling units
1764
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/10/2025
Summary of Product Characteristics
Français
01/10/2025
Summary of Product Characteristics
Italien
01/10/2025
Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
FTAB
150.0 MG Substance Wirkstoff (Principe actif)
FTAB
100.0 MG Substance Wirkstoff (Principe actif)
FTAB
50.0 MG Substance Wirkstoff (Principe actif)
FTAB
- Substance HNIDK
FTAB
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
FTAB
75.0 MG Substance Wirkstoff (Principe actif)
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
167.2 MG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FIMDK
FTAB
- Substance HNIDK
FTAB
- Substance FTODK
FTAB
- Substance FTODK
FTAB
- Substance HNIDK
FTAB
2.68 MG Substance HBESI
FTAB
- Substance FTODK
FTAB
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
FTAB
- Substance HNIDK
FTAB
1.82 MG Substance HBESI

Reimbursement information

Public price
CHF 14565.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2021

Authorization holder

Vertex Pharmaceuticals (CH) GmbH

6300 Zug

Authorization information

Swissmedic authorization number
67773
Drug name
Trikafta, Filmtabletten
Galenic form
TAB
ATC Code
R07AX32
Authorization status
Z
Dispensing category
A
First authorization
10/12/2020
Authorization expiration date
31/12/9999
IT Number
03.99.0.
Domain
Human medicine
Field of application
Mukoviszidose

Package details

Description (FR)
TRIKAFTA cpr pell 100mg/50mg/75mg + 150mg 84 pce
Description (DE)
TRIKAFTA Filmtabl 100mg/50mg/75mg + 150mg 84 Stk
Market launch
10/12/2020
Narcotic (BTM)
No

Other package sizes (1)

TRIKAFTA cpr pell 50mg/25mg/37.5mg + 75mg 84 pce
84 (4 x 21) TABL
GTIN: 7680677730023
View